| Financial Year |
March 31 2023 |
| Monetary Funds |
94,444,144.51 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,009,061.88 |
| Accounts Receivable |
310,966,170.67 |
| Advances to Suppliers |
240,863,614.36 |
| Other Receivables |
59,322,309.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
229,159,853.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
31,098,406.92 |
| Total Current Assets |
967,863,561.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
62,827,946.04 |
| Under-construction Projects |
499,673.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
69,327,767.05 |
| R&D expenses |
1,843,194.05 |
| Goodwill |
109,644,100.11 |
| Long-Term Deferred and Prepaid Expenses |
21,674,776.41 |
| Deferred Income Tax Assets |
24,630,574.85 |
| Other Non-Current Assets |
31,513,798.25 |
| Sub-Total of Non-Current Assets |
344,260,034.85 |
| Total Assets |
1,312,123,596.33 |
| Short-Term Loans |
80,024,467.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
295,043,148.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,601,045.58 |
| Taxes Payable |
4,591,743.81 |
| Interest Payable |
-- |
| Dividend Payable |
45,300.00 |
| Other payables |
339,028,147.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,782,902.03 |
| Other Current Liabilities |
3,359,108.85 |
| Sub-Total of Current Liabilities |
800,014,582.75 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
322,943,200.00 |
| Deferred Income Tax Liabilities |
2,923,876.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
338,137,912.14 |
| Total Liabilities |
1,138,152,494.89 |
| Paid-In Capital(Or Share Stock) |
1,048,590,126.00 |
| Capital Surplus |
3,214,254,953.30 |
| Surplus Reserve |
47,794,601.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-4,071,369,609.09 |
| Minority Stockholder's Interest |
16,343,533.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
157,627,567.72 |
| Owner's Equity（Stockholder's Equity） |
173,971,101.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,312,123,596.33 |
